-
Je něco špatně v tomto záznamu ?
Characterization and in vitro Analysis of Probiotic-Derived Peptides Against Multi Drug Resistance Bacterial Infections
A. Mazumdar, Y. Haddad, VP. Sur, V. Milosavljevic, S. Bhowmick, H. Michalkova, R. Guran, R. Vesely, A. Moulick,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2010
Free Medical Journals
od 2010
PubMed Central
od 2010
Europe PubMed Central
od 2010
Open Access Digital Library
od 2010-01-01
Open Access Digital Library
od 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2010
PubMed
32983007
DOI
10.3389/fmicb.2020.01963
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
An inexorable switch from antibiotics has become a major desideratum to overcome antibiotic resistance. Bacteriocin from Lactobacillus casei, a cardinal probiotic was used to design novel antibacterial peptides named as Probiotic Bacteriocin Derived and Modified (PBDM) peptides (PBDM1: YKWFAHLIKGLC and PBDM2: YKWFRHLIKKLC). The loop-shaped 3D structure of peptides was characterized in silico via molecular dynamics simulation as well as biophysically via spectroscopic methods. Thereafter, in vitro results against multidrug resistant bacterial strains and hospital samples demonstrated the strong antimicrobial activity of PBDM peptides. Further, in vivo studies with PBDM peptides showed downright recovery of balb/c mice from Vancomycin Resistant Staphylococcus aureus (VRSA) infection to its healthy condition. Thereafter, in vitro study with human epithelial cells showed no significant cytotoxic effects with high biocompatibility and good hemocompatibility. In conclusion, PBDM peptides displayed significant antibacterial activity against certain drug resistant bacteria which cause infections in human beings. Future analysis are required to unveil its mechanism of action in order to execute it as an alternative to antibiotics.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20021763
- 003
- CZ-PrNML
- 005
- 20210309110205.0
- 007
- ta
- 008
- 201125s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fmicb.2020.01963 $2 doi
- 035 __
- $a (PubMed)32983007
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Mazumdar, Aninda $u Department of Chemistry and Biochemistry, Faculty of AgriSciences, Mendel University in Brno, Brno, Czechia. Central European Institute of Technology, Brno University of Technology, Brno, Czechia.
- 245 10
- $a Characterization and in vitro Analysis of Probiotic-Derived Peptides Against Multi Drug Resistance Bacterial Infections / $c A. Mazumdar, Y. Haddad, VP. Sur, V. Milosavljevic, S. Bhowmick, H. Michalkova, R. Guran, R. Vesely, A. Moulick,
- 520 9_
- $a An inexorable switch from antibiotics has become a major desideratum to overcome antibiotic resistance. Bacteriocin from Lactobacillus casei, a cardinal probiotic was used to design novel antibacterial peptides named as Probiotic Bacteriocin Derived and Modified (PBDM) peptides (PBDM1: YKWFAHLIKGLC and PBDM2: YKWFRHLIKKLC). The loop-shaped 3D structure of peptides was characterized in silico via molecular dynamics simulation as well as biophysically via spectroscopic methods. Thereafter, in vitro results against multidrug resistant bacterial strains and hospital samples demonstrated the strong antimicrobial activity of PBDM peptides. Further, in vivo studies with PBDM peptides showed downright recovery of balb/c mice from Vancomycin Resistant Staphylococcus aureus (VRSA) infection to its healthy condition. Thereafter, in vitro study with human epithelial cells showed no significant cytotoxic effects with high biocompatibility and good hemocompatibility. In conclusion, PBDM peptides displayed significant antibacterial activity against certain drug resistant bacteria which cause infections in human beings. Future analysis are required to unveil its mechanism of action in order to execute it as an alternative to antibiotics.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Haddad, Yazan $u Department of Chemistry and Biochemistry, Faculty of AgriSciences, Mendel University in Brno, Brno, Czechia. Central European Institute of Technology, Brno University of Technology, Brno, Czechia.
- 700 1_
- $a Sur, Vishma Pratap $u Department of Chemistry and Biochemistry, Faculty of AgriSciences, Mendel University in Brno, Brno, Czechia. Central European Institute of Technology, Brno University of Technology, Brno, Czechia.
- 700 1_
- $a Milosavljevic, Vedran $u Department of Chemistry and Biochemistry, Faculty of AgriSciences, Mendel University in Brno, Brno, Czechia. Central European Institute of Technology, Brno University of Technology, Brno, Czechia.
- 700 1_
- $a Bhowmick, Sukanya $u Department of Chemistry and Biochemistry, Faculty of AgriSciences, Mendel University in Brno, Brno, Czechia. Central European Institute of Technology, Brno University of Technology, Brno, Czechia.
- 700 1_
- $a Michalkova, Hana $u Department of Chemistry and Biochemistry, Faculty of AgriSciences, Mendel University in Brno, Brno, Czechia.
- 700 1_
- $a Guran, Roman $u Department of Chemistry and Biochemistry, Faculty of AgriSciences, Mendel University in Brno, Brno, Czechia. Central European Institute of Technology, Brno University of Technology, Brno, Czechia.
- 700 1_
- $a Vesely, Radek $u Department of Traumatology at the Medical Faculty, Masaryk University and Trauma Hospital of Brno, Brno, Czechia.
- 700 1_
- $a Moulick, Amitava $u Department of Chemistry and Biochemistry, Faculty of AgriSciences, Mendel University in Brno, Brno, Czechia. Central European Institute of Technology, Brno University of Technology, Brno, Czechia.
- 773 0_
- $w MED00181714 $t Frontiers in microbiology $x 1664-302X $g Roč. 11, č. - (2020), s. 1963
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32983007 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20210309110200 $b ABA008
- 999 __
- $a ind $b bmc $g 1591472 $s 1112435
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 11 $c - $d 1963 $e 20200825 $i 1664-302X $m Frontiers in microbiology $n Front Microbiol $x MED00181714
- LZP __
- $a Pubmed-20201125